65,437 trials
Anemia
Primary: Percentage of Participants Maintaining Mean Hemoglobin Levels Within the Target Range During the Last 4 Weeks of the Treatment Period (Weeks 8 to 12) — 57.89 Percentage…
Contraception: Optional Applicator for Insertion of Vaginal Ring
Primary: Percentage of Participants With Successful Ring Insertion — 100; 100 Percentage of participants
Esophageal Cancer
Primary: Complete Pathologic Response (pCR) — 36.6 percentage of participants
Spinal Cord Injuries
Primary: Percent Change From Baseline in Volumetric Bone Mineral Density (vBMD) at 6-Months — -11; -5.7 Percent Change
Sensorimotor Gait Disorder · Neurologic Ambulation Disorder · Gait, Drop Foot
Primary: Ten Meter Walk Test (10mWT) — 0.15; 0.14 meters per second (m/s) — p=0.75
Recurrent Prostate Cancer · Stage I Prostate Cancer · Stage IIA Prostate Cancer
Primary: The Number of Patients With a PSA Decline of ≥50% — 0 participants
Carcinoma, Non Small Cell Lung
Primary: Progression Free Survival (PFS) — 16.23; 11.07 Months — p=0.009
Hip Replacement · Primary, Secondary or Post-traumatic Osteoarthrosis · Femur Head Necrosis
Primary: Number of Participants With Adverse Events — 2 participants
Obesity · Overweight · Hypertension
Primary: Change in Weight (From Baseline) — -0.71; -0.31; -1.64; -1.06 Pounds — p=0.4937
Cheyne-Stokes Respiration · Sleep Apnea, Central
Primary: Apnea/Hypopnea Index (AHI) — 55; 37; 12 Apnea-Hypopnea events per hour
- Study Focus: Renal Retention of Lipid Microbubbles
Primary: Renal Video Intensity Units — 19 units on a scale
Type 2 Diabetes Mellitus
Primary: Saxagliptin Maximum Observed Concentrations (Cmax) — 26.2; 25.5 ng/mL — p=0.4950
Glioblastoma Multiforme/Anaplastic Astrocytoma
Primary: Maximum Tolerated Dose(MTD)of Temozolomide(TMZ) — 75 mg/m^2
Failed Labor
Primary: Percentage of Women With Vaginal Deliveries — 92; 52; 88; 57 percentage of participants in each group — p=<0.01
Stroke · Brain Infarction · Brain Ischemia
Primary: Wolf Motor Function Test (WMFT) Log-transformed Time — -0.8; -0.9; -0.8 log(seconds)